* Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation (143 visite)
Greco A, Zannetti A, Pappata S, Albanese S, Coda AR, Ragucci M, Nardelli A, Brunetti A, Cuocolo A, Salvatore M
Q J Nucl Med Mol Imaging (ISSN: 1824-4785linking, 1824-4785print, 1827-1936electronic), 2018 Mar; 62(1): 112-117.
Impact Factor: 2.413
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Autocrine signals increase Ovine Mesenchymal Stem Cells migration through Aquaporin-1 and CXCR4 overexpression (49 visite)
Pelagalli A, Nardelli A, Lucarelli E, Zannetti A, Brunetti A
J Cell Physiol (ISSN: 1097-4652electronic, 0021-9541linking), 2018 Jan 18; 233(8): 6241-6249.
Impact Factor: 4.08
Dettagli    Esporta in BibTeX    Esporta in EndNote

* F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer (63 visite)
Gallicchio R, Nardelli A, Venetucci A, Capacchione D, Pelagalli A, Sirignano C, Mainenti P, Pedicini P, Guglielmi G, Storto G
EUR J RADIOL (ISSN: 0720-048X), 2017 Aug; 93: 107-113.
Impact Factor: 2.843
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells (150 visite) (PDF 210 visite)
Pelagalli A, Nardelli A, Fontanella R, Zannetti A
INT J MOL SCI (ISSN: 1422-0067), 2016 Jul 11; 17(7): N/D-N/D.
Impact Factor: 3.226
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Therapeutic Strategies in HCC: Radiation Modalities (82 visite)
Gallicchio R, Nardelli A, Mainenti P, Nappi A, Capacchione D, Simeon V, Sirignano C, Abbruzzi F, Barbato F, Landriscina M, Storto G
BIOMED RES INT (ISSN: 2314-6133), 2016; 2016: 1295329-1295329.
Impact Factor: 2.476
Dettagli    Esporta in BibTeX    Esporta in EndNote

* [F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients (71 visite)
Nappi A, Gallicchio R, Simeon V, Nardelli A, Pelagalli A, Zupa A, Vita G, Venetucci A, Di Cosola M, Barbato F, Storto G
RADIOL ONCOL (ISSN: 1318-2099), 2015 Nov 27; 49(4): 320-326.
Impact Factor: 1.736
Dettagli    Esporta in BibTeX    Esporta in EndNote

* A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion (576 visite) (PDF 171 visite)
Fontanella R, Pelagalli A, Nardelli A, D'Alterio C, Ierano C, Cerchia L, Lucarelli E, Scala S, Zannetti A
CANCER LETT (ISSN: 0304-3835), 2015 Oct 27; 370(1): 100-107.
Impact Factor: 5.992
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Evaluation of Glucose Uptake in Normal and Cancer Cell Lines by Positron Emission Tomography (149 visite)
Maddalena F, Lettini G, Gallicchio R, Sisinni L, Simeon V, Nardelli A, Venetucci AA, Storto G, Landriscina M
MOL IMAGING (ISSN: 1535-3508), 2015 Sep 1; 14: 490-498.
Impact Factor: 2.216
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Palliative Treatment Of Bone Metastases With Samarium-153 Edtmp At Onset Of Pain (126 visite)
Gallicchio R, Giacomobono S, Nardelli A, Pellegrino T, Simeon V, Gattozzi D, Maddalena F, Mainenti PP, Storto G
J BONE MINER METAB (ISSN: 0914-8779), 2014 Jul; 32(4): 434-440.
Impact Factor: 2.46
Dettagli    Esporta in BibTeX    Esporta in EndNote

* F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (112 visite)
Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, Soscia E, Pedicini P, Gattozzi D, Musto P, Storto G
EUR J HAEMATOL (ISSN: 0902-4441), 2014 May; 92(5): 382-389.
Impact Factor: 2.066
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Does remnant from differentiated thyroid microcarcinoma patients really not be treated with Iodine-131 ablation? (94 visite)
D'Antuono F, Gallicchio R, Venetucci A, Nardelli A, Giacomobono S, Pellegrino T, Tempone A, Di Leo A, Gattozzi D, Storto G
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Effects of Thyroid Blockade on Brain Imaging of Dopamine Transporter in Normal Mice (99 visite)
Greco A, Zannetti A, Coda ARD, Albanese S, Nardelli A, Roca A, Pappata S, Brunetti A, Cuocolo A
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

* F-18 FDG PET/CT quantisation parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (78 visite)
D'Antuono F, Mansueto G, Giacomobono S, Gallicchio R, Nardelli A, Pellegrino T, Tempone A, Leggiadro F, Gattozzi D, Guariglia R, Storto G
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Palliative Treatment of Bone Metastases with Sm-153 EDTMP at Pain Onset (100 visite)
D'Antuono F, Nardelli A, Gallicchio R, Giacomobono S, Venetucci A, Pellegrino T, Leggiadro F, D'Errico N, Gattozzi D, Mainenti PP, Storto G
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? (108 visite)
Gallicchio R, Giacomobono S, Capacchione D, Nardelli A, Barbato F, Nappi A, Pellegrino T, Storto G
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Oct; 44(2): 426-433.
Impact Factor: 3.527
Dettagli    Esporta in BibTeX    Esporta in EndNote

* F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer (111 visite)
Giacomobono S, Gallicchio R, Capacchione D, Nardelli A, Gattozzi D, Lettini G, Molinari L, Mainenti P, Cammarota A, Storto G
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 2013 Jul 12; 28(12): 1699-1705.
Impact Factor: 2.415
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Impact of F-18-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP (111 visite)
Storto G, Gallicchio R, Pellegrino T, Nardelli A,  De Luca S, Capacchione D, Sirignano C, Pace L
Nucl Med Biol (ISSN: 0969-8051, 0883-2897, 0969-8051linking), 2013 May; 40(4): 518-523.
Impact Factor: 2.408
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Combined Imaging with 18F-FLT PET/CT and 99m-Tc-Hynic-Annexin V SPECT for Personalized Therapy with EGFR Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer (102 visite)
Zannetti A, Iommelli F, De Rosa V, Nardelli A, Ortosecco G, Del Vecchio S
European Journal Of Cancer (ISSN: 0959-8049), 2012 Nov; 48: N/D-N/D.
Impact Factor: 5.061
Dettagli    Esporta in BibTeX    Esporta in EndNote

* F-18 FDG PET/CT metabolic tumor volume correlates with epidermal grow factor receptor expression in patients with NSCLC (91 visite)
Nappi A, Giacomobono S, Improta G, Nardelli A, Gallicchio R, Soscia E, Leggiadro F, Zupa A, Giudice G, Capacchione D, Vita G, Lequaglie C, Storto G
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Oct; 39: N/D-N/D.
Impact Factor: 5.114
Dettagli    Esporta in BibTeX    Esporta in EndNote

* F-18 FDG PET/CT metabolic tumor volume predicts outcome in patients with disseminated epithelial ovarian cancer (77 visite)
Gallicchio R, Capacchione D, Giacomobono S, Nardelli A, Bozza G, Sirignano C, Troiani L, Improta G, Tempone A, Nappi A, Storto G
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Oct; 39: N/D-N/D.
Impact Factor: 5.114
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Enhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of yttrium-90 (162 visite)
Nardelli A, Castaldi E, Ortosecco G, Speranza A, Storto G, Pace L, Salvatore M
Applied Radiation And Isotopes (ISSN: 1872-9800, 0969-8043, 0969-8043linking), 2011 Jan; 69(1): 52-55.
Impact Factor: 1.172
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma (89 visite)
Storto G, Di Giorgio E, De Renzo A, Pizzuti LM, Cerciello G, Nardelli A, Capacchione D, Castaldi E, Ortosecco G, Pace L
Br J Haematol (ISSN: 0007-1048, 0007-1048linking, 1365-2141electronic), 2010 Oct; 151(2): 195-197.
Impact Factor: 4.942
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Automatic radiosynthesis of [F-18]-FBCHO-maleimide linker for Affibody labelling (111 visite)
Castaldi E, Ortosecco G, Nardelli A, Speranza A, Del Vecchio S, Zannetti A, Storto G, Pace L, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Oct; 37: N/D-N/D.
Impact Factor: 5.036
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Does remnants from low-risk differentiated thyroid cancer patients really be not treated with Iodine-131? (84 visite)
Barbato F, Capacchione D, Nappi A, Telesca D, Tempone A, Casolino E, Nardelli A, Castaldi E, Ortosecco G, Storto G
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Oct; 37: N/D-N/D.
Impact Factor: 5.036
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Assessment of Metabolic Response to Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (112 visite)
Storto G, De Renzo A, Pellegrino T, Perna F, De Falco T, Erra P, Nardelli A, Speranza A, Klain M, Rotoli B, Pace L
Radiology (ISSN: 0033-8419, 1527-1315, 0033-8419linking), 2010 Jan; 254(1): 245-252.
Impact Factor: 6.069
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Automatic two-steps radiosynthesis of [F-18]-Fluoroacetate by commercial synthesizer (110 visite)
Ortosecco G, Castaldi E, Nardelli A, Speranza A, Storto G, Del Vecchio S, Pace L, Alfano B, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Enhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of Yttrium-90 (126 visite)
Nardelli A, Castaldi E, Ortosecco G, Speranza A, Storto G, Pellegrino T, Pace L, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

* F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer (81 visite)
Giacomobono S, Capacchione D, Lancellotti M, Nardelli A, Gallicchio R, Improta G, Nappi A, Cammarota A, Di Leo A, Pace L, Storto G
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Fully automated synthesis procedure of 4-[18F]fluorobenzaldehyde by commercial synthesizer: amino-oxi peptide labelling prosthetic group (103 visite)
Speranza A, Ortosecco G, Castaldi E, Nardelli A, Pace L, Salvatore M
Applied Radiation And Isotopes (ISSN: 1872-9800, 0969-8043, 0969-8043linking), 2009 Sep; 67(9): 1664-1669.
Impact Factor: 1.094
Dettagli    Esporta in BibTeX    Esporta in EndNote

* An Improved Radiolabeling Synthesis of RGDECHI with 18F-Fluoride (115 visite)
Panico M, Lang L, Del Vecchio S, Nardelli A, Castaldi E, Zaccaro L, Del Gatto A, Saviano M, Zannetti A, Larobina M, Gargiulo S, Pedone C, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Assessment of Metabolic Activity by PET-CT with F-18-FDG in patients with T-cell Lymphoma (113 visite)
Storto G, Di Giorgio E, Pellegrino T, Erra P, Nardelli A, Perna F, Castaldi E, Ortosecco G, Speranza A, De Renzo A, Salvatore M, Rotoli B, Pace L
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Assessment of Metabolic Response to Radioimmunotherapy (RIT) with Yttrium-90 (Y-90) Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-cell non-Hodgkin Lymphoma (85 visite)
Storto G, Nardelli A, Pellegrino T, Perna F, De Falco T, Erra P, Ortosecco G, Castaldi E, Speranza A, Klain M, De Renzo A, Di Nuzzo C, Pace L, Rotoli B, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Efficacy and Toxicity of Peptide Receptor Radionuclide Therapy (PRRT) using medium-high activities of Y-90-DOTA-Octreotate (Y-90-DOTATATE) in patients with tumours expressing somatostatin receptors (SSTR) (102 visite)
Storto G, Erra P, Pellegrino T, Nardelli A, Milone F, Di Giorgio E, Faggiano A, Castaldi E, Ortosecco G, Speranza A, Klain M, Colao A, Salvatore M, Pace L
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Fully automated labelling of [18F]Fluorobenzaldehyde and [18F]Fluorothymidine by cartridge purification (94 visite)
Nardelli A, Castaldi E, Ortosecco G, Speranza A, Storto G, Pace L, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Impact of PET-CT with F-18 Fluoride in Implementing Treatment of Painful Bone Metastases with Sm-153 EDTMP (104 visite)
Storto G, Pellegrino T, Nardelli A, De Falco T, Castaldi E, Ortosecco G, Capasso E, Erra P, Speranza A, Klain M, Molino L, Di Nuzzo C, Pace L, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Detection of liver Metastases in patients with colorectal carcinoma: Comparison of multidetector-CT, Mr, ultrasound and PET-CT (109 visite)
Mainenti PP, Mainolfi C, Storto G, Salvatore B, Nardelli A, De Marino M, Caliendo A, Nappi R, Pace L, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: N/D-N/D.
Impact Factor: 4.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Activity Threshold Determining Cumulative Aderse-Effects In Patients Undergoing Peptide Receptor Radionuclide Therapy With Y-90 Octreotate (109 visite)
Storto G, Speranza A, Pellegrino T, Panico M, Cella L, Nardelli A, Russo AA, Klain M, Soricelli A, Pace L, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006; 33: 338-338.
Impact Factor: 4.041
Dettagli    Esporta in BibTeX    Esporta in EndNote